About Hyperfine, Inc. 
Hyperfine, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 5 Schemes (6.72%)
Foreign Institutions
Held by 6 Foreign Institutions (2.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
3 Million
(Quarterly Results - Jun 2025)
Net Profit:
-9 Million
Pharmaceuticals & Biotechnology
USD 94 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.72
-115.65%
2.66






